Labatec Pharma SA - Ondansetron Labatec 8 mg, comprimés pelliculés | | 65145 | | 02 | | Ondansetron Labatec 8 mg | | comprimés pelliculés | | A04AA01 | | Ondansetron | | 21.11.2014 | | |
| Composition | Comprimé pelliculé: ondansetronum 8 mg ut ondansetroni hydrochloridum dihydricum, lactosum monohydricum 169 mg, cellulosum microcristallinum, amylum pregelificatum, magnesii stearas, pellicule: hypromellosum, hydroxypropylcellulosum, propylenglycolum, sorbitani oleas, vanillinum, E 104, E 171, E 200 pro compresso obducto. | Packungsbestandteile | | Coated tablets | | | Active Agent | Dose | additional_information |
---|
Ondansetron | 8 mg | Comprimé pelliculé |
| BAG: Active Agent | Dose |
---|
Ondansetron | 8 mg |
| | Inactive agents | Dose | additional_information |
---|
Amylum Pregelificatum | | | Cellulosum Microcristallinum | | | E 104 | | color. | E 171 | | color. | E 200 | | conserv. | Hydroxypropylcellulosum | | | Hypromellosum | | pellicule | Lactose Monohydrate | 169 mg | | Magnesii Stearas | | | Pro Compresso Obducto | | | Propylenglycol | | | Sorbitani Oleas | | | Vanilline | | |
| |
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
---|
002 | 6 Tablet(s) | 20.56 | 38.85 | B | SL | Yes | 003 | 10 Tablet(s) | PR | PR | B | | Yes |
|
|